These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34247756)

  • 1. Atrial Fibrillation in Patients with Chronic Kidney Disease.
    Kotalczyk A; Ding WY; Wong CF; Rao A; Gupta D; Lip GYH
    Cardiol Clin; 2021 Aug; 39(3):435-446. PubMed ID: 34247756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease.
    Potpara TS; Jokic V; Dagres N; Larsen TB; Lane DA; Hindricks G; Lip GY
    Curr Med Chem; 2016; 23(19):2055-69. PubMed ID: 26861000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease.
    Arnson Y; Hoshen M; Berliner-Sendrey A; Reges O; Balicer R; Leibowitz M; Avgil Tsadok M; Haim M
    Cardiology; 2020; 145(3):178-186. PubMed ID: 31955174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.
    Bansal VK; Herzog CA; Sarnak MJ; Choi MJ; Mehta R; Jaar BG; Rocco MV; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):859-868. PubMed ID: 28941763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulants in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Ingram AJ; Herzog CA
    Nat Rev Nephrol; 2012 Oct; 8(10):569-78. PubMed ID: 22825670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation.
    Stamellou E; Floege J
    Nephrol Dial Transplant; 2018 Oct; 33(10):1683-1689. PubMed ID: 29206932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
    Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
    Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.
    Washam JB; Holmes DN; Thomas LE; Pokorney SD; Hylek EM; Fonarow GC; Mahaffey KW; Gersh BJ; Kowey PR; Ansell JE; Go AS; Reiffel JA; Freeman JV; Singer DE; Naccarelli G; Blanco R; Peterson ED; Piccini JP
    J Am Heart Assoc; 2018 Sep; 7(18):e008928. PubMed ID: 30371218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Ahmad Y; Lip GY
    Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
    Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
    G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and chronic kidney disease in Asian Population, Data from the COOL-AF Thailand registry.
    Chantrarat T; Krittayaphong R
    Int J Cardiol; 2021 Jan; 323():90-99. PubMed ID: 32828960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Quandary of Oral Anticoagulation in Patients With Atrial Fibrillation and Chronic Kidney Disease.
    Schwartzenberg S; Lev EI; Sagie A; Korzets A; Kornowski R
    Am J Cardiol; 2016 Feb; 117(3):477-82. PubMed ID: 26721651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New oral anticoagulants in patients with chronic kidney disease.
    Belmar Vega L; de Francisco ALM; Bada da Silva J; Galván Espinoza L; Fernández Fresnedo G
    Nefrologia; 2017; 37(3):244-252. PubMed ID: 27939514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into Concomitant Atrial Fibrillation and Chronic Kidney Disease.
    Wang Y; Yang Y; He F
    Rev Cardiovasc Med; 2022 Mar; 23(3):105. PubMed ID: 35345272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction.
    Mahmood M; Lip GYH
    Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):847-855. PubMed ID: 29958809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.
    Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR;
    Am J Kidney Dis; 2017 Jun; 69(6):734-743. PubMed ID: 27998624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.